Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Change in Account Payables (2018 - 2024)

Historic Change in Account Payables for Abvc Biopharma (ABVC) over the last 10 years, with Q3 2024 value amounting to $92972.0.

  • Abvc Biopharma's Change in Account Payables rose 11864.89% to $92972.0 in Q3 2024 from the same period last year, while for Sep 2024 it was -$252400.0, marking a year-over-year decrease of 98967.22%. This contributed to the annual value of $242469.0 for FY2022, which is 17640.24% up from last year.
  • Abvc Biopharma's Change in Account Payables amounted to $92972.0 in Q3 2024, which was up 11864.89% from $24326.0 recorded in Q2 2024.
  • In the past 5 years, Abvc Biopharma's Change in Account Payables registered a high of $849033.0 during Q4 2020, and its lowest value of -$627020.0 during Q3 2020.
  • For the 5-year period, Abvc Biopharma's Change in Account Payables averaged around $15685.7, with its median value being $23893.5 (2022).
  • Per our database at Business Quant, Abvc Biopharma's Change in Account Payables surged by 72950.64% in 2020 and then plummeted by 212979.69% in 2023.
  • Abvc Biopharma's Change in Account Payables (Quarter) stood at $849033.0 in 2020, then tumbled by 158.41% to -$495928.0 in 2021, then surged by 137.12% to $184067.0 in 2022, then plummeted by 370.85% to -$498538.0 in 2023, then soared by 118.65% to $92972.0 in 2024.
  • Its Change in Account Payables stands at $92972.0 for Q3 2024, versus $24326.0 for Q2 2024 and $128840.0 for Q1 2024.